Evidence map›Paper›PMID 31085149›Full record

ReviewHematology, transfusion and cell therapy

Trypanosoma cruzi infection in transfusion medicine.

Lina Andrea Gómez, Fredy R S Gutierrez, Oscar Andres Peñuela

Abstract readReview
In one paragraph

Review in Hematology, transfusion and cell therapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Chagas Disease in Europe.Tropical medicine and infectious disease · 2023
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Trypanocidal Mechanism of Action andInternational journal of molecular sciences · 2019
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lina Andrea GómezBiomedical Research Center (CIBUS), School of Medicine, Universidad de la Sabana, Chía, Colombia. Electronic address: linagore@unisabana.edu.co.
Fredy R S GutierrezLaboratory of Immunology, School of Medicine, Antonio Nariño University, Bogotá, Colombia.
Oscar Andres PeñuelaMedical Affairs, Bayer S.A., Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionInfection by Trypanosoma cruzi is challenging to blood bank supplies in terms of accurate diagnosis, mostly due to its clinical complexity. Infected individuals may remain asymptomatic for years, albeit they may have circulating parasites potentially transferable to eventual receptors of a transfusion.

objectiveAlthough risk donors are systematically excluded through a survey, an important residual risk for transmission remains, evidencing the need to implement additional actions for the detection of T. cruzi in blood banks.

methodA review of the scientific literature is presented with the objective of identifying relevant publications on this subject.

resultsWe discuss the diagnostic considerations of this chronic infection on transfusion medicine and some recent advances in the processing of blood and derivatives units.

conclusionFinally, recommendations are made on how the transmission of T. cruzi can be avoided through the implementation of better diagnostic and pathogen control measures at blood banks.

Indexed as

Blood banksBlood safetyEpidemiological factorsHemoparasiteHemovigilanceTrypanosoma cruzi

Identifiers

PMID31085149
PMCPMC6732405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.